Status:
RECRUITING
Olfactory Outcomes of Dupilumab Treatment for Nasal Polyposis
Lead Sponsor:
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Collaborating Sponsors:
Mount Sinai Hospital, Canada
Conditions:
Chronic Rhinosinusitis With Nasal Polyps
Olfactory Disorder
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
The study aims to investigate the olfactory TDI score (Threshold, Discrimination, Identification) using the Sniffin' sticks test for patients with chronic rhinosinusitis with nasal polyps (CRSwNP) on ...
Eligibility Criteria
Inclusion
- Patients older than 18 years old
- Chronic rhinosinusitis with Nasal Polyps
- Olfactory loss
- Clinical indication for treatment with Dupilumab
Exclusion
- Patients with olfactory loss from other causes such as:
- Sinonasal malignancies
- Trauma
- Idiopathic olfactory loss
- Use of cocaine
- COVID-19 related olfactory loss
- Pregnancy
Key Trial Info
Start Date :
July 19 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2025
Estimated Enrollment :
27 Patients enrolled
Trial Details
Trial ID
NCT04869436
Start Date
July 19 2021
End Date
December 1 2025
Last Update
December 20 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
St. Joseph's Health Care
London, Ontario, Canada, N5A 4V2